ROYAL BANK OF CANADA - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 28 filers reported holding PROTEON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$10,000
+42.9%
4,398
+14.3%
0.00%
Q3 2018$7,000
-22.2%
3,848
+0.6%
0.00%
Q2 2018$9,000
-10.0%
3,8250.0%0.00%
Q1 2018$10,000
+42.9%
3,8250.0%0.00%
Q4 2017$7,0000.0%3,825
+13.3%
0.00%
Q3 2017$7,000
-22.2%
3,375
-43.2%
0.00%
Q2 2017$9,000
-40.0%
5,940
-32.6%
0.00%
Q1 2017$15,000
-34.8%
8,815
-27.1%
0.00%
Q4 2016$23,000
+283.3%
12,090
+1760.0%
0.00%
Q3 2016$6,000
-45.5%
650
-16.2%
0.00%
Q3 2015$11,000
+37.5%
776
+63.4%
0.00%
Q2 2015$8,0004750.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$525,0000.33%
Deer VII & Co. Ltd. 315,101$82,0000.10%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,224,899$318,0000.01%
Opaleye Management Inc. 54,000$14,0000.01%
WEDBUSH SECURITIES INC 166,472$43,0000.00%
PVG ASSET MANAGEMENT CORP 10,000$2,600,0000.00%
Virtu Financial LLC 90,376$23,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 57,600$15,0000.00%
Renaissance Technologies 767,422$200,0000.00%
Creative Planning 24,304$6,0000.00%
View complete list of PROTEON THERAPEUTICS INC shareholders